| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jul―30 |
The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation |
Yuxin Zhang, Tong-Yun Wang, Huihui Yan, Zhoule Guo, Zhonghao Lian, Hailan Yao, Shuofeng Yuan, Xing-Yi Ge, Ye Qiu |
| 2 |
[GO] |
2025―Jun―23 |
THAP11-mediated K48- and K63-linked ubiquitination is essential for the degradation of porcine reproductive and respiratory syndrome virus nonstructural protein 1β |
Binghua Chen, Yongsheng Xie, Zhan He, Yongjie Chen, Jiecong Yan, Fangfang Li, Yunyan Luo, Yanfei Pan, Min Liu, Chunhe Guo |
| 3 |
[GO] |
2025―Mai―21 |
Inflammatory metabolite 7α,25-OHC promotes TIMP1 expression in COVID-19 monocytes through synergy effect of SMARCC1/JUND/H3K27ac |
Ying Feng, Zheng Wu, Kefan Hu, Shenzhen Yuan, Jun Li, Yi Wang, Zhongyi Wang, Han Yang, Zhi-Hui Luo, Jingjiao Zhou |
| 4 |
[GO] |
2025―Mrz―13 |
Anti-interferon armamentarium of human coronaviruses |
Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi |
| 5 |
[GO] |
2024―Dez―03 |
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors |
Karthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, Chiara Massa, Tuula Salo, Katharina Biehl, Christoforos K. Vaxevanis, Kamatchi Ulagappan, Wafa Wahbi, Matthias Reimers, Felix Drexler, Andres Moreira-Soto, Michael Bachmann, Barbara Seliger |
| 6 |
[GO] |
2024―Dez―03 |
Heterogeneous neutrophils in lung transplantation and proteolytic CXCL8 activation in COVID-19, influenza and lung transplant patient lungs |
Seppe Cambier, Fabio Beretta, Amber Nooyens, Mieke Metzemaekers, Noëmie Pörtner, Janne Kaes, Ana Carolina de Carvalho, Emanuela E. Cortesi, Hanne Beeckmans, Charlotte Hooft, Mieke Gouwy, Sofie Struyf, Rafael E. Marques, Laurens J. Ceulemans, Joost Wauters, Bart M. Vanaudenaerde, Robin Vos, Paul Proost |
| 7 |
[GO] |
2024―Okt―12 |
MERS-CoV-nsp5 expression in human epithelial BEAS 2b cells attenuates type I interferon production by inhibiting IRF3 nuclear translocation |
Y. Zhang, S. Kandwal, D. Fayne, N. J. Stevenson |
| 8 |
[GO] |
2024―Sep―16 |
Enhanced complement activation and MAC formation accelerates severe COVID-19 |
Calder R. Ellsworth, Zheng Chen, Mark T. Xiao, Chaosi Qian, Chenxiao Wang, Mst Shamima Khatun, Shumei Liu, Mohammad Islamuddin, Nicholas J. Maness, Jose A. Halperin, Robert V. Blair, Jay K. Kolls, Stephen Tomlinson, Xuebin Qin |
| 9 |
[GO] |
2024―Sep―07 |
Human coronaviruses activate and hijack the host transcription factor HSF1 to enhance viral replication |
Silvia Pauciullo, Anna Riccio, Silvia Santopolo, Anna Albecka, Guido Papa, Leo C. James, Sara Piacentini, Giulia Lanzilli, Antonio Rossi, M. Gabriella Santoro |
| 10 |
[GO] |
2024―Aug―23 |
Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period |
Hyunkyung Cha, Chan Mi Lee, Sujin Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Yoon Kyung Jeon, Hyeon Jae Jo, Nam Joong Kim, Wan Beom Park, Hyun Jik Kim |
| 11 |
[GO] |
2024―Aug―15 |
SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses |
Thien-Phong Vu Manh, Carla Gouin, Julien De Wolf, Luc Jouneau, Florentina Pascale, Claudia Bevilacqua, Meriadeg Ar Gouilh, Bruno Da Costa, Christophe Chevalier, Matthieu Glorion, Laurent Hannouche, Céline Urien, Jérôme Estephan, Antoine Magnan, Morgan Le Guen, Quentin Marquant, Delphyne Descamps, Marc Dalod, Isabelle Schwartz-Cornil, Edouard Sage |
| 12 |
[GO] |
2024―Jul―27 |
SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition |
Nieves Lara-Ureña, Elena Gómez-Marín, Isabel Pozuelo-Sánchez, José C. Reyes, Mario García-Domínguez |
| 13 |
[GO] |
2024―Mai―28 |
Disruption of pulmonary microvascular endothelial barrier by dysregulated claudin-8 and claudin-4: uncovered mechanisms in porcine reproductive and respiratory syndrome virus infection |
Weifeng Sun, Weixin Wu, Xinyu Fang, Xinna Ge, Yongning Zhang, Jun Han, Xin Guo, Lei Zhou, Hanchun Yang |
| 14 |
[GO] |
2024―Feb―18 |
Emerging role of complement in COVID-19 and other respiratory virus diseases |
Mark T. Xiao, Calder R. Ellsworth, Xuebin Qin |
| 15 |
[GO] |
2023―Nov―20 |
SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction |
Oyahida Khatun, Mansi Sharma, Rohan Narayan, Shashank Tripathi |
| 16 |
[GO] |
2023―Nov―09 |
The KxGxYR and DxE motifs in the C-tail of the Middle East respiratory syndrome coronavirus membrane protein are crucial for infectious virus assembly |
Lowiese Desmarets, Adeline Danneels, Julien Burlaud-Gaillard, Emmanuelle Blanchard, Jean Dubuisson, Sandrine Belouzard |
| 17 |
[GO] |
2023―Okt―05 |
Entropy driven cooperativity effect in multi-site drug optimization targeting SARS-CoV-2 papain-like protease |
Lili Duan, Bolin Tang, Song Luo, Danyang Xiong, Qihang Wang, Xiaole Xu, John Z. H. Zhang |
| 18 |
[GO] |
2023―Jul―28 |
Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients |
Seppe Cambier, Fabio Beretta, Noëmie Pörtner, Mieke Metzemaekers, Ana Carolina de Carvalho, Erik Martens, Janne Kaes, Celine Aelbrecht, Cato Jacobs, Pierre Van Mol, Els Wauters, Philippe Meersseman, Greet Hermans, Rafael Elias Marques, Bart Vanaudenaerde, Robin Vos, Joost Wauters, Mieke Gouwy, Paul Proost |
| 19 |
[GO] |
2023―Mai―07 |
Neuronal progenitors of the dentate gyrus express the SARS-CoV-2 cell receptor during migration in the developing human hippocampus |
José Manuel Hernandez-Lopez, Cristina Hernandez-Medina, Cristina Medina-Corvalan, Mónica Rodenas, Almagro Francisca, Claudia Perez-Garcia, Diego Echevarria, Francisco Carratala, Emilio Geijo-Barrientos, Salvador Martinez |
| 20 |
[GO] |
2022―Dez―03 |
Neutrophils play a major role in the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters |
Clara Bourgon, Audrey St Albin, Ophélie Ando-Grard, Bruno Da Costa, Roxane Domain, Brice Korkmaz, Bernard Klonjkowski, Sophie Le Poder, Nicolas Meunier |
| 21 |
[GO] |
2022―Nov―05 |
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection |
Barbara Seliger, Simon Jasinski-Bergner, Chiara Massa, Anja Mueller, Katharina Biehl, Bo Yang, Michael Bachmann, Danny Jonigk, Philip Eichhorn, Arndt Hartmann, Claudia Wickenhauser, Marcus Bauer |
| 22 |
[GO] |
2022―Jul―16 |
The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses |
Philippe Roingeard, Sébastien Eymieux, Julien Burlaud-Gaillard, Christophe Hourioux, Romuald Patient, Emmanuelle Blanchard |
| 23 |
[GO] |
2022―Jun―16 |
Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19 |
Aiwei Zhu, Fernando Real, Claude Capron, Arielle R. Rosenberg, Aymeric Silvin, Garett Dunsmore, Jaja Zhu, Andréa Cottoignies-Callamarte, Jean-Marc Massé, Pierre Moine, Simon Bessis, Mathieu Godement, Guillaume Geri, Jean-Daniel Chiche, Silvana Valdebenito, Sandrine Belouzard, Jean Dubuisson, Geoffroy Lorin de la Grandmaison, Sylvie Chevret, Florent Ginhoux, Eliseo A. Eugenin, Djillali Annane, Elisabeth Cramer Bordé, Morgane Bomsel |
| 24 |
[GO] |
2022―Jun―13 |
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels |
Erika Cecon, Daniela Fernandois, Nicolas Renault, Caio Fernando Ferreira Coelho, Jan Wenzel, Corentin Bedart, Charlotte Izabelle, Sarah Gallet, Sophie Le Poder, Bernard Klonjkowski, Markus Schwaninger, Vincent Prevot, Julie Dam, Ralf Jockers |
| 25 |
[GO] |
2022―Mai―21 |
Role of LL-37 in thrombotic complications in patients with COVID-19 |
Zilei Duan, Juan Zhang, Xue Chen, Ming Liu, Hongwen Zhao, Lin Jin, Zhiye Zhang, Ning Luan, Ping Meng, Jing Wang, Zhaoxia Tan, Yaxiong Li, Guohong Deng, Ren Lai |
| 26 |
[GO] |
2022―Mai―19 |
Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming |
Sadiq Umar, Karol Palasiewicz, Anja Meyer, Prabhakaran Kumar, Bellur S. Prabhakar, Michael V. Volin, Rani Rahat, Mina Al-Awqati, Huan J. Chang, Ryan K. Zomorrodi, Jalees Rehman, Shiva Shahrara |
| 27 |
[GO] |
2022―Apr―07 |
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence |
Anna Riccio, Silvia Santopolo, Antonio Rossi, Sara Piacentini, Jean-Francois Rossignol, M. Gabriella Santoro |
| 28 |
[GO] |
2022―Mrz―13 |
Hematopoietic responses to SARS-CoV-2 infection |
Shokrollah Elahi |
| 29 |
[GO] |
2022―Feb―20 |
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications |
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, Qi Zhang, Lingzhi Fan, Yangxin Fang, Yifei Li, Charlie Xiang |
| 30 |
[GO] |
2022―Feb―20 |
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection |
Russel J. Reiter, Ramaswamy Sharma, Fedor Simko, Alberto Dominguez-Rodriguez, Jan Tesarik, Richard L. Neel, Andrzej T. Slominski, Konrad Kleszczynski, Verna M. Martin-Gimenez, Walter Manucha, Daniel P. Cardinali |
| 31 |
[GO] |
2022―Jan―17 |
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells |
Davide Barbagallo, Concetta Ilenia Palermo, Cristina Barbagallo, Rosalia Battaglia, Angela Caponnetto, Vittoria Spina, Marco Ragusa, Cinzia Di Pietro, Guido Scalia, Michele Purrello |
| 32 |
[GO] |
2022―Jan―10 |
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses |
André Schreiber, Dorothee Viemann, Jennifer Schöning, Sebastian Schloer, Angeles Mecate Zambrano, Linda Brunotte, Aileen Faist, Michael Schöfbänker, Eike Hrincius, Helen Hoffmann, Markus Hoffmann, Stefan Pöhlmann, Ursula Rescher, Oliver Planz, Stephan Ludwig |
| 33 |
[GO] |
2021―Nov―06 |
Carbon dioxide inhibits COVID-19-type proinflammatory responses through extracellular signal-regulated kinases 1 and 2, novel carbon dioxide sensors |
Hanna Galganska, Wieslawa Jarmuszkiewicz, Lukasz Galganski |
| 34 |
[GO] |
2021―Nov―03 |
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants |
Deepali Gupta, Priyanka Sharma, Mandeep Singh, Mukesh Kumar, A. S. Ethayathulla, Punit Kaur |
| 35 |
[GO] |
2021―Okt―29 |
Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 |
Andrei E. Siniavin, Maria A. Streltsova, Maria A. Nikiforova, Denis S. Kudryavtsev, Svetlana D. Grinkina, Vladimir A. Gushchin, Vera A. Mozhaeva, Vladislav G. Starkov, Alexey V. Osipov, Sarah C. R. Lummis, Victor I. Tsetlin, Yuri N. Utkin |
| 36 |
[GO] |
2021―Jul―05 |
Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs |
Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, Michael Kreuter, Jule Rüter, Srinivas Reddy Pallerla, Thirumalaisamy P. Velavan, Dennis Nurjadi |
| 37 |
[GO] |
2021―Jan―15 |
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release |
Sébastien Eymieux, Yves Rouillé, Olivier Terrier, Karin Seron, Emmanuelle Blanchard, Manuel Rosa-Calatrava, Jean Dubuisson, Sandrine Belouzard, Philippe Roingeard |
| 38 |
[GO] |
2020―Aug―11 |
Advances in research on ACE2 as a receptor for 2019-nCoV |
Jie Wu, Wei Deng, Shumin Li, Xiuhong Yang |
| 39 |
[GO] |
2020―Jul―25 |
Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses |
Rajanish Giri, Taniya Bhardwaj, Meenakshi Shegane, Bhuvaneshwari R. Gehi, Prateek Kumar, Kundlik Gadhave, Christopher J. Oldfield, Vladimir N. Uversky |
| 40 |
[GO] |
2020―Jul―04 |
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies |
Ivan Mercurio, Vincenzo Tragni, Francesco Busto, Anna De Grassi, Ciro Leonardo Pierri |
|
